Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: Identification of a novel mutation in inhA

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 3, 2006, Pages 1075-1078

  Leung, E T Y ^a   Ho, P L ^a   Yuen, K Y ^a   Woo, W L ^a   Lam, T H ^a   Kao, R Y ^a   Seto, W H ^a   Yam, W C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; ISONIAZID; PROTEIN INHA; UNCLASSIFIED DRUG;

ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CHINA; DNA SEQUENCE; GENE; GENE MUTATION; INHA GENE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; STRAIN IDENTIFICATION;

ALLELES; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; CODON; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HUMANS; ISONIAZID; KINETICS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PEROXIDASES; POINT MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 33644680148     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.3.1075-1078.2006     Document Type: Article

References (22)

1. Baker, L. V., T. J. Brown, O. Maxwell, A. L. Gibson, Z. Fang, M. D. Yates, and F. A. Drobniewski. 2005. Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism. Antimicrob. Agents Chemother. 49:1455-1464.
2. Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, K. S. Um, T. Wilson, D. Collins, G. de Lisle, and W. R. Jacobs, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230.
3. Basso, L. A., R. Zheng, J. M. Musser, W. R. Jacobs, Jr., and J. S. Blanchard. 1998. Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates. J. Infect. Dis. 178:769-775.
4. Ducasse-Cabanot, S., M. Cohen-Gonsaud, H. Marrakchi, M. Nguyen, D. Zerbib, J. Bernadou, M. Daffe, G. Labesse, and A. Quemard. 2004. In vitro inhibition of the Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein reductase MabA by isoniazid. Antimicrob. Agents Chemother. 48:242-249.
5. Gomes-Guimaraes, B., H. Souchon, N. Honore, B. Saint-Joanis, R. Brosch, W. Shepard, S. T. Cole, and P. M. Alzari. 2005. Structure and mechanism of the alkyl hydroperoxidase AhpC, a key element of the Mycobacterium tuberculosis defense system against oxidative stress. J. Biol. Chem. 280:25735-25742.
6. Herrera-León, L., T. Molina, P. Saíz, J. A. Sáez-Nieto, and M. Soledad Jiménez. 2005. New multiplex PCR for rapid detection of isoniazid-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob. Agents Chemother. 49:144-147.
7. Kelley, C. L., D. A. Rouse, and S. L. Morris. 1997. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41:2057-2058.
8. Koshkin, A., X. T. Zhou, C. N. Kraus, J. M. Brenner, P. Bandyopadhyay, I. D. Kuntz, C. E. Barry III, and P. R. Ortiz de Montellano. 2004. Inhibition of Mycobacterium tuberculosis AhpD, an element of the peroxiredoxin defense against oxidative stress. Antimicrob. Agents Chemother. 48:2424-2430.
9. Leung, E. T., K. M. Kam, A. Chiu, P. L. Ho, W. H. Seto, K. Y. Yuen, and W. C. Yam. 2003. Detection of katG Ser315Thr substitution in respiratory specimens from patients with isoniazid-resistant Mycobacterium tuberculosis using PCR-RFLP. J. Med. Microbiol. 52:999-1003.
10. Mdluli, K., R. A. Slayden, Y. Zhu, S. Ramaswamy, X. Pan, D. Mead, D. D. Crane, J. M. Musser, and C. E. Barry III. 1998. Inhibition of a Mycobacterium tuberculosis β-ketoacyl ACP synthase by isoniazid. Science 280:1607-1610.
11. Miesel, L., T. R. Weisbrod, J. A. Marcinkeviciene, R. Bittman, and W. R. Jacobs, Jr. 1998. NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis. J. Bacteriol. 180:2459-2467.
12. Mokrousov, I., T. Otten, M. Filipenko, A. Vyazovaya, E. Chrapov, E. Limeschenko, L. Steklova, B. Vyshnevskiy, and O. Narvskaya. 2002. Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-specific PCR assay targeting katG codon 315 variation. J. Clin. Microbiol. 40:2509-2512.
13. NCCLS. 2000. Susceptibility testing of mycobacteria, nocardia and other aerobic actinomycetes. Tentative standard MT24-T2, vol. 20, 26. NCCLS, Wayne, Pa.
14. Quémard, A., J. C. Sacchettini, A. Dessen, C. Vilchèzes, R. Bittman, W. R. Jacobs, Jr., and J. S. Blanchard. 1995. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 34:8235-8241.
15. Rawat, R., A. Whitty, and P. J. Tonge. 2003. The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance. Proc. Natl. Acad. Sci. USA 100:13881-13886.
16. Rozwarski, D. A., G. A. Grant, D. H. R. Barton, W. R. Jacobs, Jr., and J. C. Sacchettini. 1998. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279:98-102.
17. Schroeder, E. K., L. A. Basso, D. S. Santos, and O. N. de Souza. 2005. Molecular dynamics simulation studies of the wild-type, I21V, and I16T mutants of isoniazid-resistant Mycobacterium tuberculosis enoyl reductase (InhA) in complex with NADH: toward the understanding of NADH-InhA different affinities. Biophys. J. 89:876-884.
18. Toungoussova, O., P. Sandven, A. Mariandyshev, N. Nizovtseva, G. Bjune, and D. A. Caugant. 2002. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J. Clin. Microbiol. 40:1930-1937.
19. Woo, P. C., K. H. Ng, S. K. Lau, K. T. Yip, A. M. Fung, K. W. Leung, D. M. Tam, T. L. Que, and K. Y. Yuen. 2003. Usefulness of the MicroSeq 500 16S ribosomal DNA-based bacterial identification system for identification of clinically significant bacterial isolates with ambiguous biochemical profiles. J. Clin. Microbiol. 41:1996-2001.
20. World Health Organization. 2005. Global tuberculosis control- surveillance, planning, financing. WHO/HTM/TB/2005.349. World Health Organization, Geneva, Switzerland.
21. Yam, W. C., C. M. Tam, C. C. Leung, H. L. Tong, K. H. Chan, E. T. Leung, K. C. Wong, W. W. Yew, W. H. Seto, K. Y. Yuen, and P. L. Ho. 2004. Direct detection of rifampin-resistant Mycobacterium tuberculosis in respiratory specimens by PCR-DNA sequencing. J. Clin. Microbiol. 42:4438-4443.
22. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591-593.